Position in EYPT
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,668,674
-$1,777,979 QoQ
Shares Held
129,455
-31.4% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. EYPT ranks #221 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,668,674 | 129,455 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,446,653 | 188,651 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,986,334 | 350,164 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,187,164 | 126,160 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,097,968 | 387,079 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,246,692 | 570,026 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,205,259 | 401,159 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,652,156 | 189,903 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,438,458 | 456,626 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $13,269,044 | 574,169 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,209,514 | 526,848 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $780,024 | 89,658 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,058 | 700 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,450 | 700 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $4,746 | 600 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,722 | 600 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $18,516 | 1,524 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $395,987 | 32,352 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,586 | 1,016 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,696 | 1,746 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,090 | 501 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,290 | 500 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||